The Coronary Drug Eluting Balloon (DEB) is an advanced angioplasty device designed to deliver an antiproliferative drug directly to the vessel wall during balloon inflation, helping to reduce restenosis without leaving a permanent implant. Engineered for excellent deliverability, uniform drug transfer, and optimal balloon compliance, it ensures effective lesion treatment while preserving the natural vessel anatomy. Its low-profile design, superior trackability, and reliable performance make it an ideal solution for treating in-stent restenosis, small vessel disease, and selected de novo coronary lesions.